LOADING
Comparing Apple Inc (AAPL) and AbbVie Inc (ABBV) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AAPL | ABBV |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $4.52T | $467.4B |
| P/E Ratio | 35.6 | 74.7 |
| Forward P/E | 32.6 | 18.9 |
| PEG Ratio | 2.50 | 0.43 |
| EPS | $8.71 | $3.54 |
| Revenue Growth (YoY) | 16.4% | 10.2% |
| Profit Margin | 27.6% | 9.8% |
| Return on Equity | 148.8% | 62.3% |
| Dividend Yield | 0.34% | 2.58% |
| Beta | 1.09 | 0.28 |
| 52-Week High | $344.27 | $267.47 |
| 52-Week Low | $225.12 | $189.40 |
| Volume | -- | -- |
Apple Inc is the larger company by market capitalization. Apple Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Apple Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.